On Dec. 3, FDA’s Consumer Healthcare Information announced that women and their health care providers can look forward to getting more useful and up-to-date information over the next few years about the effects of medicines during pregnancy and breastfeeding.
The improvements will replace the current, decades-old labeling system and implement new requirements by FDA regarding labeling information for prescription drugs and biological products. The changes will include major revisions in the subsections about pregnancy and breastfeeding.
